{
  "trial_id": "NCT01986855",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of type 2 diabetes mellitus, estimated glomerular filtration rate (eGFR), baseline hemoglobin A1C (A1C), baseline antihyperglycemic therapy, history of cardiovascular disease, history of chronic kidney disease, race/ethnicity, smoking status, blood pressure, lipid profile, liver function tests, renal function tests, baseline fasting plasma glucose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "baseline hemoglobin A1C (A1C)"
        ],
        [
          "Baseline Estimated glomerular filtration rate (eGFR)",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Baseline Fasting Plasma Glucose (FPG)",
          "baseline fasting plasma glucose."
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Baseline Weight",
        "Stratification Factor: Insulin at randomization"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes mellitus",
        "baseline antihyperglycemic therapy",
        "history of cardiovascular disease",
        "history of chronic kidney disease",
        "race/ethnicity",
        "smoking status",
        "blood pressure",
        "lipid profile",
        "liver function tests",
        "renal function tests"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), duration of type 2 diabetes mellitus, estimated glomerular filtration rate (eGFR), baseline hemoglobin A1C (A1C), baseline antihyperglycemic therapy, history of cardiovascular disease, history of chronic kidney disease, race/ethnicity, smoking status, blood pressure, lipid profile, liver function tests, renal function tests, baseline fasting plasma glucose."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Estimated Glomerular Filtration Rate (eGFR), Blood Pressure, Use of Antihyperglycemic Agents,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "Baseline HbA1c"
        ],
        [
          "Baseline Estimated glomerular filtration rate (eGFR)",
          "Estimated Glomerular Filtration Rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Baseline Weight",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Stratification Factor: Insulin at randomization"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Blood Pressure",
        "Use of Antihyperglycemic Agents"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Estimated Glomerular Filtration Rate (eGFR), Blood Pressure, Use of Antihyperglycemic Agents"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, HbA1c, History of Cardiovascular Disease, History of Hypertension, History of Hyperlipidemia, Use of Antihyperglycemic Agents, Use of Antihypertensive Agents, Use of Lipid-Lowering Agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "HbA1c"
        ],
        [
          "Baseline Estimated glomerular filtration rate (eGFR)",
          "eGFR"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Baseline Weight",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Stratification Factor: Insulin at randomization"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "History of Cardiovascular Disease",
        "History of Hypertension",
        "History of Hyperlipidemia",
        "Use of Antihyperglycemic Agents",
        "Use of Antihypertensive Agents",
        "Use of Lipid-Lowering Agents"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, HbA1c, History of Cardiovascular Disease, History of Hypertension, History of Hyperlipidemia, Use of Antihyperglycemic Agents, Use of Antihypertensive Agents, Use of Lipid-Lowering Agents."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, estimated glomerular filtration rate (eGFR), hemoglobin A1C (A1C) at baseline, systolic blood pressure, diastolic blood pressure, history of hypertension, history of cardiovascular disease, history of myocardial infarction, history of stroke, history of heart failure, use of antihyperglycemic agents, use of antihypertensive agents, use of lipid-lowering agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "hemoglobin A1C (A1C) at baseline"
        ],
        [
          "Baseline Estimated glomerular filtration rate (eGFR)",
          "estimated glomerular filtration rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Baseline Weight",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Stratification Factor: Insulin at randomization"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes mellitus",
        "systolic blood pressure",
        "diastolic blood pressure",
        "history of hypertension",
        "history of cardiovascular disease",
        "history of myocardial infarction",
        "history of stroke",
        "history of heart failure",
        "use of antihyperglycemic agents",
        "use of antihypertensive agents",
        "use of lipid-lowering agents"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, estimated glomerular filtration rate (eGFR), hemoglobin A1C (A1C) at baseline, systolic blood pressure, diastolic blood pressure, history of hypertension, history of cardiovascular disease, history of myocardial infarction, history of stroke, history of heart failure, use of antihyperglycemic agents, use of antihypertensive agents, use of lipid-lowering agents."
  }
}